| Typ : |
Časopis |
|
| Výskumné tímy : |
Vancouver - Children\'s and Women\'s Health Center of British Columbia |
| Autori : |
Ensom MHH, Decarie D, Sheppard I. |
| Titul : |
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration. |
| Référence : |
Can J Hosp Pharm ; 60, 3: 184-191. 2007 |
|
| Úroveň dôkazu : |
|
| Fyzikálna stabilita : |
|
| Chemická stabilita : |
|
| Iné metódy : |
|
| Komentáre : |
|
Zoznam zlúčenín
 Lansoprazole
|
 |
 |
 |
 |
150 mg
®=? (Abbott Laboratories) |
|
25°C |
 |
| 91 |
 |
|
|
|
|
|
150 mg
®=? (Abbott Laboratories) |
| NaHCO3 8.4% |
25 ml |
| NaOH |
1N = 1.7 ml |
| OraPlus® / OraSweet® (1:1) |
23.3 ml |
| PH= |
8.4 |
|
25°C |
|
| 91 |
|
|
|
|
|
|
150 mg
®=? (Abbott Laboratories) |
|
4°C |
 |
| 91 |
|
|
|
|
|
|
150 mg
®=? (Abbott Laboratories) |
| NaHCO3 8.4% |
25 ml |
| NaOH |
1N = 1.7 ml |
| OraPlus® / OraSweet® (1:1) |
23.3 ml |
| PH= |
8.4 |
|
4°C |
|
| 91 |
|
|
|
|
|
